mapping the effectiveness and risks of glp-1 receptor agonists Author Correction: GLP-1 Receptor Agonist Market Growth
Description
Extreme/rapid weight loss may result in nutritional deficiencies that lead to hair loss, anemia, weak bones or increased risk of infection
They interact with metabolic signalling pathways that influence inflammation, insulin sensitivity, and gut hormone secretion
Meanwhile, risks could still develop with longer term GLP-1 receptor agonist use
If you currently take any prescription medications - particularly antidepressants, anti-anxiety medications, migraine medications, blood sugar medications, or any serotonergic drugs - consult your physician and pharmacist before starting this or any new supplement
Membership is additional
